stella
beta
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma — Stella
Recruiting
Back to Uveal Melanoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
United States
University of Colorado Cancer Center, Aurora, Colorado
Georgetown University Medical Center, Washington D.C., District of Columbia
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
View full record on ClinicalTrials.gov